These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 323834)

  • 61. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical experience with furosemide.
    Herrmann GR; Ghiselli RG
    South Med J; 1968 Oct; 61(10):1083-8. PubMed ID: 5746300
    [No Abstract]   [Full Text] [Related]  

  • 63. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Potassium and magnesium depletion in patients with cirrhosis on maintenance diuretic regimens.
    Wheeler PG; Smith T; Golindano C; Alam AN; Wilkinson SP; Edmonds CJ; Williams R
    Gut; 1977 Sep; 18(9):683-7. PubMed ID: 604188
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Association of furosemide and amiloride in patients with essential hypertension. Effect on the excretion of Na, K, Cl and on urine volume].
    Chávez de Los Rios JM; Otero Cagide F; Alfaro Cano L; Gatica Laborde V
    Prensa Med Mex; 1978; 43(3-4):89-94. PubMed ID: 364462
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs.
    Jeunesse E; Woehrle F; Schneider M; Lefebvre HP
    J Vet Cardiol; 2007 Nov; 9(2):63-8. PubMed ID: 18024236
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice.
    Crawford RJ; Allman S; Gibson W; Kitchen S; Richards HH
    J Int Med Res; 1988; 16(2):143-9. PubMed ID: 3378660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Comparative study of pharmacokinetics and effects on urinary secretion of electrolytes of furosemide and furosemide-amiloride in healthy subjects].
    Kantelip JP; Aiache JM; Beyssac E; Abella ML
    Therapie; 1991; 46(6):475-9. PubMed ID: 1819153
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relative potency of prorenoate and spironolactone in normal man.
    Ramsay L; Harrison I; Shelton J; Tidd M
    Clin Pharmacol Ther; 1975 Oct; 18(4):391-400. PubMed ID: 1100306
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of triamterene on potassium excretion in cirrhotic patients receiving furosemide.
    Thompson EJ; Torres E; Grosberg SJ; Martinez-Maldonado M
    Clin Pharmacol Ther; 1977 Apr; 21(4):392-4. PubMed ID: 321176
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Potassium-sparing effect of amiloride in a diuretic factorial study in man.
    Schapel GJ; Edwards DG; Robinson J
    Clin Exp Pharmacol Physiol; 1975; 2(4):277-87. PubMed ID: 1097143
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The use of glucocorticoids for diuresis in patients with fluid retention not resulting from renal disease.
    Jick H
    Ann N Y Acad Sci; 1966 Nov; 139(2):512-9. PubMed ID: 5230292
    [No Abstract]   [Full Text] [Related]  

  • 74. Diuretic effect of a combined preparation of frusemide and slow-release potassium chloride.
    Davis B; Warrington SJ
    Curr Med Res Opin; 1978; 5(9):739-42. PubMed ID: 738078
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Effect of diuretic measures in hydropic conditions. I. Planning, results in heart insufficiency].
    Kaufmann W; Dürr F; Neuhaus GA; Praetorius F; Horbach L; Michaelis J
    Klin Wochenschr; 1969 Nov; 47(21):1130-42. PubMed ID: 5382002
    [No Abstract]   [Full Text] [Related]  

  • 76. Spironolactone dose-response relationships in healthy subjects.
    McInnes GT; Perkins RM; Shelton JR; Harrison IR
    Br J Clin Pharmacol; 1982 Apr; 13(4):513-8. PubMed ID: 7066166
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites.
    El-Bokl MA; Senousy BE; El-Karmouty KZ; Mohammed Iel K; Mohammed SM; Shabana SS; Shalaby H
    World J Gastroenterol; 2009 Aug; 15(29):3631-5. PubMed ID: 19653340
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dose-response relationships for spironolactone in combination with a potassium-wasting diuretic.
    McInnes GT; Clarke JM; Shelton JR
    Clin Pharmacol Ther; 1983 Jan; 33(1):35-43. PubMed ID: 6848297
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Muscle strength, Na,K-pumps, magnesium and potassium in patients with alcoholic liver cirrhosis -- relation to spironolactone.
    Aagaard NK; Andersen H; Vilstrup H; Clausen T; Jakobsen J; Dørup I
    J Intern Med; 2002 Jul; 252(1):56-63. PubMed ID: 12074739
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of severe edema in children with nephrotic syndrome with diuretics alone--a prospective study.
    Kapur G; Valentini RP; Imam AA; Mattoo TK
    Clin J Am Soc Nephrol; 2009 May; 4(5):907-13. PubMed ID: 19406963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.